{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:36:41Z","timestamp":1790239001627,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/cid\/ciy577","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T11:34:20Z","timestamp":1531568060000},"page":"699-704","source":"Crossref","is-referenced-by-count":60,"title":["Bezlotoxumab"],"prefix":"10.1093","volume":"68","author":[{"given":"Stuart","family":"Johnson","sequence":"first","affiliation":[{"name":"Hines Veterans Affairs Hospital, Hines, Illinois"},{"name":"Loyola University Medical Center, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale N","family":"Gerding","sequence":"additional","affiliation":[{"name":"Hines Veterans Affairs Hospital, Hines, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"key":"key\n\t\t\t\t2019013123594734600_CIT0001","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/IAI.47.2.349-352.1985","article-title":"Effects of Clostridium difficile toxins given intragastrically to animals","volume":"47","author":"Lyerly","year":"1985","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/gmic.26854","article-title":"Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance","volume":"5","author":"Gerding","year":"2014","journal-title":"Gut Microbes"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/jit426","article-title":"Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain","volume":"209","author":"Kuehne","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/501368","article-title":"Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters","volume":"193","author":"Geric","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.27.1.78","article-title":"Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon","volume":"27","author":"Mitchell","year":"1986","journal-title":"Gut"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0006","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1128\/JCM.38.7.2706-2714.2000","article-title":"Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea","volume":"38","author":"Alfa","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0007","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s100960100550","article-title":"Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain","volume":"20","author":"Kuijper","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-135-6-200109180-00012","article-title":"Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay","volume":"135","author":"Johnson","year":"2001","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0009","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nature07822","article-title":"Toxin B is essential for virulence of Clostridium difficile","volume":"458","author":"Lyras","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","article-title":"The role of toxin A and toxin B in Clostridium difficile infection","volume":"467","author":"Kuehne","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0011","doi-asserted-by":"crossref","first-page":"e00551","DOI":"10.1128\/mBio.00551-15","article-title":"Defining the roles of tcdA and tcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections","volume":"6","author":"Carter","year":"2015","journal-title":"MBio"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0012","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/IAI.63.12.4619-4627.1995","article-title":"Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters","volume":"63","author":"Torres","year":"1995","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0013","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/IAI.66.5.2018-2025.1998","article-title":"Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection","volume":"66","author":"Kink","year":"1998","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0014","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.00041-08","article-title":"Tolevamer, an anionic polymer, neutralizes toxins produced by the BI\/027 strains of Clostridium difficile","volume":"52","author":"Hinkson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0016","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/IAI.00982-06","article-title":"Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters","volume":"74","author":"Babcock","year":"2006","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0017","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1074\/jbc.M114.560748","article-title":"Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography","volume":"289","author":"Orth","year":"2014","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0018","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1074\/jbc.M117.806687","article-title":"Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants","volume":"292","author":"Gupta","year":"2017","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0019","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jmb.2017.02.010","article-title":"Epitopes and mechanism of action of the Clostridium difficile toxin A-neutralizing antibody actoxumab","volume":"429","author":"Hernandez","year":"2017","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0020","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.04433-14","article-title":"Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling","volume":"59","author":"Hernandez","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/IAI.02550-14","article-title":"Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection","volume":"83","author":"Zhang","year":"2015","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0022","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0024","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.vaccine.2009.10.144","article-title":"Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)","volume":"28","author":"Leav","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0025","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1172\/JCI27821","article-title":"Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria","volume":"116","author":"Yoshida","year":"2006","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0026","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection","volume":"376","author":"Wilcox","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0027","volume-title":"Zinplava (bezlotoxumab) [package insert]","year":"2016"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0028","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0029","article-title":"Assessment of efficacy of bezlotoxumab for prevention of Clostridium difficile infection recurrence by diagnostic test method","volume-title":"European Congress of Clinical Microbiology and Infectious Diseases","author":"Wilcox","year":"2016"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0030","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy171","article-title":"Bezlotoxumab for prevention of recurrent C. difficile infection in patients with increased risk","author":"Gerding","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0031","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cix523","article-title":"Thirty-day readmissions in hospitalized patients who received bezlotoxumab with antibacterial drug treatment for Clostridium difficile infection","volume":"65","author":"Prabhu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0032","first-page":"49","article-title":"Bezlotoxumab (Zinplava) for prevention of recurrent Clostridium difficile infection","volume":"59","year":"2017","journal-title":"Med Lett Drugs Ther"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0033","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/cix809","article-title":"Cost-effectiveness of bezlotoxumab compared with placebo for the prevention of recurrent Clostridium difficile infection","volume":"66","author":"Prabhu","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019013123594734600_CIT0034","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1525-1497.1998.00211.x","article-title":"Interpretation of cost-effectiveness analyses","volume":"13","author":"Owens","year":"1998","journal-title":"J Gen Intern Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/4\/699\/27662826\/ciy577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T23:38:32Z","timestamp":1604619512000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/4\/699\/5055410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,7,18]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy577","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,15]]},"published":{"date-parts":[[2018,7,18]]}}}